NA Gastric Cancer Diagnostics Market - Industry Trends and Forecast to 2030
Description
NA Gastric Cancer Diagnostics Market - Industry Trends and Forecast to 2030
North America gastric cancer diagnostics market is projected to register a CAGR of 8.5% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentation:
North America Gastric Cancer Diagnostics Market, By Product Type (Instruments, Reagents & Consumables, Services), Diagnostics Type (Gastric (Pre) Cancer Screening Tests/Physical Exam, Confirmatory Tests), Age Group (Adult, Pediatric, and Geriatrics), Type (Intestinal Or Diffuse Adenocarcinoma, Carcinoid Tumor, Gastrointestinal Stromal Tumor (GIST), Gastric Lymphoma and Others), Stage (Stage 0, Stage I, Stage II, Stage III), Gender (Male and Female), Sample Type (Blood, Tissue, Urine, and Stool), End Users (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Distribution Channel (Direct Tenders and Retail Sales), Country (U.S., Canada, Mexico) Industry Trends and Forecast To 2030
Some of the major factors contributing to the growth of the North America gastric cancer diagnostics market are:
• Rising healthcare expenditure for better health services
• Increase in diagnostic procedures for gastric cancer
• Growing prevalence of gastric cancer
Market Players:
Some of the key market players in the North America gastric cancer diagnostics market are listed below:
• BIOMÉRIEUX
• Myriad Genetics, Inc.
• ACON Laboratories, Inc.
• Teco Diagnostics
• Vela Diagnostics
• Abbott
• AdvaCare Pharma
• MiRXES Pte Ltd.
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd
• General Electric
• Agilent Technologies, Inc.
• Biohit Oyj,
• BIOCEPT, INC.
• FOUNDATION MEDICINE, INC.
• DiaSorin S.p.A
• Paragon Genomics, Inc.
• QIAGEN
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
North America gastric cancer diagnostics market is projected to register a CAGR of 8.5% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentation:
North America Gastric Cancer Diagnostics Market, By Product Type (Instruments, Reagents & Consumables, Services), Diagnostics Type (Gastric (Pre) Cancer Screening Tests/Physical Exam, Confirmatory Tests), Age Group (Adult, Pediatric, and Geriatrics), Type (Intestinal Or Diffuse Adenocarcinoma, Carcinoid Tumor, Gastrointestinal Stromal Tumor (GIST), Gastric Lymphoma and Others), Stage (Stage 0, Stage I, Stage II, Stage III), Gender (Male and Female), Sample Type (Blood, Tissue, Urine, and Stool), End Users (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Distribution Channel (Direct Tenders and Retail Sales), Country (U.S., Canada, Mexico) Industry Trends and Forecast To 2030
Some of the major factors contributing to the growth of the North America gastric cancer diagnostics market are:
• Rising healthcare expenditure for better health services
• Increase in diagnostic procedures for gastric cancer
• Growing prevalence of gastric cancer
Market Players:
Some of the key market players in the North America gastric cancer diagnostics market are listed below:
• BIOMÉRIEUX
• Myriad Genetics, Inc.
• ACON Laboratories, Inc.
• Teco Diagnostics
• Vela Diagnostics
• Abbott
• AdvaCare Pharma
• MiRXES Pte Ltd.
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd
• General Electric
• Agilent Technologies, Inc.
• Biohit Oyj,
• BIOCEPT, INC.
• FOUNDATION MEDICINE, INC.
• DiaSorin S.p.A
• Paragon Genomics, Inc.
• QIAGEN
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
225 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The North America Gastric Cancer Diagnostics Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Product Type Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Vendor Share Analysis
- 2.11 Market End Coverage Grid
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insight
- 4.1 Pestel's Model
- 4.2 Porter's 5 Forces
- 4.3 Epidemiology
- 4.4 Brand Analysis
- 4.5 Role Of Artificial Intelligence (Ai) And Machine Learning (Ml): North America Gastric Cancer Diagnostics Market
- 4.6 Industry Insights:
- 5 North America Gastric Cancer Diagnostics Market, Regulatory
- 5.1 North America
- 5.1.1 Regulatory Scenario In The U.S
- 6 Market Overview
- 6.1 Drivers
- 6.1.1 Increase In Incidence Of Gastrointestinal Tumours, Lymphoma, And Adenocarcinoma
- 6.1.2 Rise In Alcohol Consumption And Surge In Smoking
- 6.1.3 Increase In The Geriatric Population
- 6.1.4 Recent Advancements In Gastric Cancer Diagnostics Products
- 6.2 Restraints
- 6.2.1 High Cost Of Gastric Cancer Diagnostic Test
- 6.2.2 Lack Of Sufficient Financial Support From Health Insurance Policies
- 6.3 Opportunities
- 6.3.1 Rise In The Adoption Of Automated Systems
- 6.3.2 Increased Research And Development On Cancer Diagnostics Products
- 6.3.3 Strategic Initiatives By Emerging Players
- 6.4 Challenges
- 6.4.1 Stringent Regulations And Policies For Approving The Complicated Nature Of Radiation Devices
- 6.4.2 Limitations Of Radiation Tests
- 7 North America Gastric Cancer Diagnostics Market, By Product Type
- 7.1 Overview
- 7.2 Reagents & Consumables
- 7.2.1 Kits
- 7.2.1.1 Dna Polymerase Kits
- 7.2.1.2 Pcr Kits
- 7.2.1.3 Nucleic Acid Isolation Kits
- 7.2.1.4 Others
- 7.2.2 Reagents
- 7.2.2.1 Assays
- 7.2.2.2 Buffers
- 7.2.2.3 Primers
- 7.2.2.4 Others
- 7.3 Instruments
- 7.4 Services
- 8 North America Gastric Cancer Diagnostics Market, By Diagnostic Type
- 8.1 Overview
- 8.2 Confirmatory Test
- 8.2.1 Imaging Tests
- 8.2.1.1 Pet Scan/Ct Scan
- 8.2.1.2 Ct Scan
- 8.2.1.3 Ultrasound
- 8.2.1.4 Mri
- 8.2.1.5 X-ray
- 8.2.2 Biomarker
- 8.2.2.1 Dna Biomarker
- 8.2.2.2 Rna Biomarker
- 8.2.2.3 Protein Biomarker
- 8.2.3 Biopsy
- 8.3 Gastric Cancer Screening Tests/Physical Exam
- 9 North America Gastric Cancer Diagnostics Market, By Age Group
- 9.1 Overview
- 9.2 Geriatrics
- 9.3 Adult
- 9.4 Pediatric
- 10 North America Gastric Cancer Diagnostics Market, By Disease Type
- 10.1 Overview
- 10.2 Intestinal Or Diffuse Adenocarcinoma
- 10.3 Carcinoid Tumor
- 10.4 Gastrointestinal Stromal Tumor
- 10.5 Gastric Lymphoma
- 10.6 Others
- 11 North America Gastric Cancer Diagnostics Market, By Stage
- 11.1 Overview
- 11.2 Stage I
- 11.2.1 Stage Ia
- 11.2.2 Stage Ib
- 11.3 Stage Ii
- 11.3.1 Stage Iia
- 11.3.2 Stage Iib
- 11.4 Stage Iii
- 11.4.1 Stage Iiia
- 11.4.2 Stage Iiib
- 11.4.3 Stage Iiic
- 11.5 Stage 0
- 12 North America Gastric Cancer Diagnostics Market, By Gender
- 12.1 Overview
- 12.2 Male
- 12.3 Female
- 13 North America Gastric Cancer Diagnostics Market, By Sample Type
- 13.1 Overview
- 13.2 Stool
- 13.3 Tissue
- 13.4 Blood
- 13.5 Urine
- 14 North America Gastric Cancer Diagnostics Market, By End User
- 14.1 Overview
- 14.2 Hospitals
- 14.3 Diagnostic Laboratories
- 14.4 Cancer Research Institutes
- 14.5 Oncology Specialty Clinics
- 14.6 Others
- 15 North America Gastric Cancer Diagnostics Market, By Distribution Channel
- 15.1 Overview
- 15.2 Direct Tenders
- 15.3 Retail Sales
- 16 North America Gastric Cancer Diagnostics Market, By Region
- 16.1 North America
- 16.1.1 U.S.
- 16.1.2 Canada
- 16.1.3 Mexico
- 17 North America Gastric Cancer Diagnostics Market, Company Landscape
- 17.1 Company Share Analysis: North America
- 18 Swot Analysis
- 19 Company Profile
- 19.1 F. Hoffmann-la Roche Ltd
- 19.1.1 Company Snapshot
- 19.1.2 Revenue Analysis
- 19.1.3 Company Share Analysis
- 19.1.4 Product Portfolio
- 19.1.5 Recent Development
- 19.2 General Electric
- 19.2.1 Company Snapshot
- 19.2.2 Revenue Analysis
- 19.2.3 Company Share Analysis
- 19.2.4 Product Portfolio
- 19.2.5 Recent Development
- 19.3 Abbott
- 19.3.1 Company Snapshot
- 19.3.2 Revenue Analysis
- 19.3.3 Company Share Analysis
- 19.3.4 Product Portfolio
- 19.3.5 Recent Development
- 19.4 Qiagen
- 19.4.1 Company Snapshot
- 19.4.2 Revenue Analysis
- 19.4.3 Company Share Analysis
- 19.4.4 Product Portfolio
- 19.4.5 Recent Development
- 19.5 Myriad Genetics, Inc.
- 19.5.1 Company Snapshot
- 19.5.2 Revenue Analysis
- 19.5.3 Company Share Analysis
- 19.5.4 Product Portfolio
- 19.5.5 Recent Development
- 19.6 Acon Laboratories, Inc.
- 19.6.1 Company Snapshot
- 19.6.2 Product Portfolio
- 19.6.3 Recent Development
- 19.7 Advacare Pharma
- 19.7.1 Company Snapshot
- 19.7.2 Product Portfolio
- 19.7.3 Recent Development
- 19.8 Agilent Technologies, Inc.
- 19.8.1 Company Snapshot
- 19.8.2 Revenue Analysis
- 19.8.3 Product Portfolio
- 19.8.4 Recent Developments
- 19.9 Biomérieux
- 19.9.1 Company Snapshot
- 19.9.2 Revenue Analysis
- 19.9.3 Product Portfolio
- 19.9.4 Recent Development
- 19.10 Biocept, Inc.
- 19.10.1 Company Snapshot
- 19.10.2 Revenue Analysis
- 19.10.3 Product Portfolio
- 19.10.4 Recent Development
- 19.11 Biohit Oyj
- 19.11.1 Company Snapshot
- 19.11.2 Revenue Analysis
- 19.11.3 Product Portfolio
- 19.11.4 Recent Development
- 19.12 Diasorin S.P.A
- 19.12.1 Company Snapshot
- 19.12.2 Revenue Analysis
- 19.12.3 Product Portfolio
- 19.12.4 Recent Development
- 19.13 Endofotonics Pte Ltd
- 19.13.1 Company Snapshot
- 19.13.2 Product Portfolio
- 19.13.3 Recent Development
- 19.14 Foundation Medicine, Inc.
- 19.14.1 Company Snapshot
- 19.14.2 Product Portfolio
- 19.14.3 Recent Developments
- 19.15 Fujirebio (An H.U. Group Company)
- 19.15.1 Company Snapshot
- 19.15.2 Revenue Analysis
- 19.15.3 Product Portfolio
- 19.15.4 Recent Development
- 19.16 Mirxes Pte Ltd.
- 19.16.1 Company Snapshot
- 19.16.2 Product Portfolio
- 19.16.3 Recent Development
- 19.17 Paragon Genomics, Inc.
- 19.17.1 Company Snapshot
- 19.17.2 Product Portfolio
- 19.17.3 Recent Developments
- 19.18 Teco Diagnostics
- 19.18.1 Company Snapshot
- 19.18.2 Product Portfolio
- 19.18.3 Recent Development
- 19.19 Thermo Fisher Scientific Inc.
- 19.19.1 Company Snapshot
- 19.19.2 Revenue Analysis
- 19.19.3 Product Portfolio
- 19.19.4 Recent Developments
- 19.20 Vela Diagnostics
- 19.20.1 Company Snapshot
- 19.20.2 Product Portfolio
- 19.20.3 Recent Developments
- 20 Questionnaire
- 21 Related Reports 225
- List Of Tables
- Table 1 Approved Companion Diagnostic Device
- Table 2 The Below-mentioned List Shows The Cost Of Pet Scan For Cancer Diagnosis In Different Regions Across The Globe-
- Table 3 North America Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 4 North America Reagents & Consumables In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 5 North America Reagent And Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 6 North America Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 7 North America Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 8 North America Instruments In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 9 North America Services In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 10 North America Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 11 North America Confirmatory Test In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 12 North America Confirmatory Test In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 13 North America Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 14 North America Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 15 North America Gastric Cancer Screening Tests/Physical Exam In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 16 North America Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 17 North America Geriatrics In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 18 North America Adult In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 19 North America Pediatric In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 20 North America Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
- Table 21 North America Intestinal Or Diffuse Adenocarcinoma In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 22 North America Carcinoid Tumor In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 23 North America Gastrointestinal Stromal Tumor In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 24 North America Gastric Lymphoma In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 25 North America Others In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 26 North America Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 27 North America Stage I In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 28 North America Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 29 North America Stage Ii In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 30 North America Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 31 North America Stage Iii In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 32 North America Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 33 North America Stage 0 In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 34 North America Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
- Table 35 North America Male In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 36 North America Female In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 37 North America Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
- Table 38 North America Stool In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 39 North America Tissue In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 40 North America Blood In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 41 North America Urine In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 42 North America Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 43 North America Hospitals In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 44 North America Diagnostic Laboratories In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 45 North America Cancer Research Institutes In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 46 North America Oncology Specialty Clinics In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 47 North America Others In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 48 North America Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 49 North America Direct Tenders In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 50 North America Retail Sales In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 51 North America Gastric Cancer Diagnostics Market, By Country, 2021-2030 (Usd Million)
- Table 52 North America Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 53 North America Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 54 North America Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 55 North America Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 56 North America Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 57 North America Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 58 North America Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 59 North America Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 60 North America Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 61 North America Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
- Table 62 North America Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 63 North America Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 64 North America Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 65 North America Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 66 North America Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
- Table 67 North America Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
- Table 68 North America Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 69 North America Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 70 U.S. Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 71 U.S. Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 72 U.S. Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 73 U.S. Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 74 U.S. Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 75 U.S. Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 76 U.S. Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 77 U.S. Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 78 U.S. Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 79 U.S. Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
- Table 80 U.S. Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 81 U.S. Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 82 U.S. Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 83 U.S. Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 84 U.S. Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
- Table 85 U.S. Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
- Table 86 U.S. Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 87 U.S. Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 88 Canada Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 89 Canada Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 90 Canada Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 91 Canada Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 92 Canada Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 93 Canada Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 94 Canada Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 95 Canada Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 96 Canada Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 97 Canada Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
- Table 98 Canada Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 99 Canada Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 100 Canada Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 101 Canada Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 102 Canada Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
- Table 103 Canada Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
- Table 104 Canada Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 105 Canada Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 106 Mexico Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 107 Mexico Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 108 Mexico Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 109 Mexico Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 110 Mexico Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 111 Mexico Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 112 Mexico Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 113 Mexico Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 114 Mexico Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 115 Mexico Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
- Table 116 Mexico Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 117 Mexico Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 118 Mexico Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 119 Mexico Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 120 Mexico Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
- Table 121 Mexico Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
- Table 122 Mexico Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 123 Mexico Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million) 158
- List Of Figures
- Figure 1 North America Gastric Cancer Diagnostics Market: Segmentation
- Figure 2 North America Gastric Cancer Diagnostics Market: Data Triangulation
- Figure 3 North America Gastric Cancer Diagnostics Market: Droc Analysis
- Figure 4 North America Gastric Cancer Diagnostics Market: North America Vs. Regional Market Analysis
- Figure 5 North America Gastric Cancer Diagnostics Market: Company Research Analysis
- Figure 6 North America Gastric Cancer Diagnostics Market: Multivariate Modelling
- Figure 7 North America Gastric Cancer Diagnostics Market: Interview Demographics
- Figure 8 North America Gastric Cancer Diagnostics Market: Dbmr Market Position Grid
- Figure 9 North America Gastric Cancer Diagnostics Market: Vendor Share Analysis
- Figure 10 North America Gastric Cancer Diagnostics Market: Market End Coverage Grid
- Figure 11 North America Gastric Cancer Diagnostics Market: Segmentation
- Figure 12 Increase In The Incidence Of Gastrointestinal Tumors, Lymphoma, And Adenocarcinoma Is Expected To Drive The North America Gastric Cancer Diagnostics Market Growth In The Forecast Period Of 2023 To 2030
- Figure 13 Reagents And Consumables Segment Is Expected To Account For The Largest Share Of The North America Gastric Cancer Diagnostics Market In 2023 & 2030
- Figure 14 Drivers, Restraints, Opportunities, And Challenges, Of The North America Gastric Cancer Diagnostics Market
- Figure 15 North America Gastric Cancer Diagnostics Market: By Product Type, 2022
- Figure 16 North America Gastric Cancer Diagnostics Market: By Product Type, 2023-2030 (Usd Million)
- Figure 17 North America Gastric Cancer Diagnostics Market: By Product Type, Cagr (2023-2030)
- Figure 18 North America Gastric Cancer Diagnostics Market: By Product Type, Lifeline Curve
- Figure 19 North America Gastric Cancer Diagnostics Market: By Diagnostic Type, 2022
- Figure 20 North America Gastric Cancer Diagnostics Market: By Diagnostic Type, 2023-2030 (Usd Million)
- Figure 21 North America Gastric Cancer Diagnostics Market: By Diagnostic Type, Cagr (2023-2030)
- Figure 22 North America Gastric Cancer Diagnostics Market: By Diagnostic Type, Lifeline Curve
- Figure 23 North America Gastric Cancer Diagnostics Market: By Age Group, 2022
- Figure 24 North America Gastric Cancer Diagnostics Market: By Age Group, 2023-2030 (Usd Million)
- Figure 25 North America Gastric Cancer Diagnostics Market: By Age Group, Cagr (2023-2030)
- Figure 26 North America Gastric Cancer Diagnostics Market: By Age Group, Lifeline Curve
- Figure 27 North America Gastric Cancer Diagnostics Market: By Disease Type, 2022
- Figure 28 North America Gastric Cancer Diagnostics Market: By Disease Type, 2023-2030 (Usd Million)
- Figure 29 North America Gastric Cancer Diagnostics Market: By Disease Type, Cagr (2023-2030)
- Figure 30 North America Gastric Cancer Diagnostics Market: By Disease Type, Lifeline Curve
- Figure 31 North America Gastric Cancer Diagnostics Market: By Stage, 2022
- Figure 32 North America Gastric Cancer Diagnostics Market: By Stage, 2023-2030 (Usd Million)
- Figure 33 North America Gastric Cancer Diagnostics Market: By Stage, Cagr (2023-2030)
- Figure 34 North America Gastric Cancer Diagnostics Market: By Stage, Lifeline Curve
- Figure 35 North America Gastric Cancer Diagnostics Market: By Gender, 2022
- Figure 36 North America Gastric Cancer Diagnostics Market: By Gender, 2023-2030 (Usd Million)
- Figure 37 North America Gastric Cancer Diagnostics Market: By Gender, Cagr (2023-2030)
- Figure 38 North America Gastric Cancer Diagnostics Market: By Gender, Lifeline Curve
- Figure 39 North America Gastric Cancer Diagnostics Market: By Sample Type, 2022
- Figure 40 North America Gastric Cancer Diagnostics Market: By Sample Type, 2023-2030 (Usd Million)
- Figure 41 North America Gastric Cancer Diagnostics Market: By Sample Type, Cagr (2023-2030)
- Figure 42 North America Gastric Cancer Diagnostics Market: By Sample Type, Lifeline Curve
- Figure 43 North America Gastric Cancer Diagnostics Market: By End User, 2022
- Figure 44 North America Gastric Cancer Diagnostics Market: By End User, 2023-2030 (Usd Million)
- Figure 45 North America Gastric Cancer Diagnostics Market: By End User, Cagr (2023-2030)
- Figure 46 North America Gastric Cancer Diagnostics Market: By End User, Lifeline Curve
- Figure 47 North America Gastric Cancer Diagnostics Market: By Distribution Channel, 2022
- Figure 48 North America Gastric Cancer Diagnostics Market: By Distribution Channel, 2023-2030 (Usd Million)
- Figure 49 North America Gastric Cancer Diagnostics Market: By Distribution Channel, Cagr (2023-2030)
- Figure 50 North America Gastric Cancer Diagnostics Market: By Distribution Channel, Lifeline Curve
- Figure 51 North America Gastric Cancer Diagnostics Market: Snapshot (2022)
- Figure 52 North America Gastric Cancer Diagnostics Market: By Country (2022)
- Figure 53 North America Gastric Cancer Diagnostics Market: By Country (2023 & 2030)
- Figure 54 North America Gastric Cancer Diagnostics Market: By Country (2022 & 2030)
- Figure 55 North America Gastric Cancer Diagnostics Market: By Product Type (2023-2030)
- Figure 56 North America Gastric Cancer Diagnostics Market: Company Share 2022 (%) 158
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
